Loading component...

Prior authorization automation

Prior authorization means pre-approval for certain medications, treatments, or therapies, and is required by many health insurance plans. Today’s streamlined, standards-based prior authorization workflows are helping teams to accelerate approvals, reduce administrative burden, and improve patient access.

Infor_3D Platform Image_Library_Dark_06.jpg

In the healthcare industry, prior authorization approval delays can have life-altering consequences. That’s why industry groups and regulatory bodies are stepping in with guidelines to minimize red tape and help patients and healthcare teams get faster, more reliable outcomes. Prior authorization automation plays a key role by standardizing submissions, accelerating approvals and appeals, and reducing the administrative burden on an already stressed system.

What is prior authorization? 

Also known as a pre-authorization, prior authorization is a requirement by insurance companies to pre-approve specific services or medications before covering them. Its main purpose is to ensure that payers approve only medically necessary requests in accordance with their coverage policies. Most of us are familiar with common examples, such as filling a prescription at your local pharmacy. The pharmacist submits a pre-authorization request to your insurance company to determine how much, if anything, will be covered under your plan. Dentists also frequently send pre-authorization requests before performing services like a root canal to clarify how much you may need to contribute.

The pre-authorization process

The prior authorization process consists of reviewing payer rules to determine whether a particular treatment or medication is covered under the patient’s insurance plan, submitting a request, and then waiting for an approval or denial.

In many cases, additional information must be supplied to complete the request, or an alternative option may be suggested. A common example is a request for coverage for a medication that is being used for something other than its primarily intended purpose – such as diabetes drugs for weight loss. Because this is considered an “off-label” use, many insurance companies will not pay for it. The drug will only be covered as appropriately therapeutic if a physician can demonstrate that other treatment options have been exhausted. For example, the patient has obesity-related health risks, and a drug like Ozempic or Wegovy is essential to their treatment plan.

Prior authorization challenges in healthcare

The required back-and-forth between payers and providers can create a number of persistent challenges:

  • Approval delays. The main issue with the prior authorization process is the time required for requests to be submitted and approved. Payer rules vary widely, requiring providers to identify criteria for each case, submit requests in specific formats, and navigate workflows that are often manual and error-prone. Payers must verify requirements before issuing decisions, while patients wait for treatment or lifesaving medication, or pay out of pocket to move forward. The burden, cost, and delays affect everyone involved.
  • Negative patient outcomes. A national survey by the American Medical Association (AMA) found that 93% of physicians believe prior authorization negatively impacts clinical outcomes, and 94% say it delays necessary care. Additionally, 24% reported that it has led to serious adverse events, including hospitalization, permanent impairment, or death. Research published on Science Direct links delayed care from prior authorization to measurable harm across oncology, cardiology, behavioral health, and pediatrics.
  • Increased burden on physicians. Physicians spend about 13 hours per week completing roughly 40 prior authorization requests, according to the AMA. That time adds to already demanding workloads and diverts attention from patient care. Gathering documentation, responding to payer follow-ups, and navigating plan-specific requirements contribute to ongoing administrative strain.
  • Regulatory compliance. Government agencies and clinical advocacy groups are responding to prior authorization delays with new requirements. The U.S. Centers for Medicare and Medicaid Services (CMS) has issued rules requiring certain payers to implement electronic prior authorization and standardize data exchange. Meeting turnaround deadlines, reporting requirements, and interoperability expectations often requires system upgrades, API implementation, and adoption of healthcare data standards.

Loading component...

Loading component...

Loading component...

Conclusion 

By accelerating the prior authorization process, well-designed automation saves time for overworked healthcare clinicians and helps prevent costly and dangerous delays in delivering critical medications and treatments. Through integration engines, standards-based data exchange, and secure cloud architecture, modern prior authorization automation enables consistent communication across systems while maintaining clinical oversight and regulatory accountability. The result is a more predictable, efficient process that supports patient access to care without compromising compliance or trust.

See how Infor Cloverleaf, our award-winning healthcare integration platform, facilitates automated prior authorization between healthcare systems. 

Infor Cloverleaf

Loading component...

Loading component...